Patents by Inventor Alison Bamberg

Alison Bamberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190336579
    Abstract: Embodiments herein concern compositions and methods for treating a subject having or suspected of developing a pulmonary disorder or cancer. Certain embodiments concern modulating protein tyrosine phosphatase non-receptor type 13 (PTPN13) expression and/or activity in a subject to treat uncontrolled cellular growth in the subject.
    Type: Application
    Filed: March 5, 2019
    Publication date: November 7, 2019
    Inventors: David W.H. Riches, Alison Bamberg
  • Publication number: 20180028611
    Abstract: Embodiments herein concern compositions and methods for treating a subject having or suspected of developing a pulmonary disorder or cancer. Certain embodiments concern modulating protein tyrosine phosphatase non-receptor type 13 (PTPN13) expression and/or activity in a subject to treat uncontrolled cellular growth in the subject.
    Type: Application
    Filed: April 17, 2017
    Publication date: February 1, 2018
    Inventors: David W.H. Riches, Alison Bamberg
  • Publication number: 20130230486
    Abstract: Embodiments herein concern compositions and methods for treating a subject having or suspected of developing a pulmonary disorder or cancer. Certain embodiments concern modulating protein tyrosine phosphatase non-receptor type 13 (PTP-N13) expression and/or activity in a subject to treat uncontrolled cellular growth in the subject.
    Type: Application
    Filed: November 8, 2011
    Publication date: September 5, 2013
    Inventors: David W.H. Riches, Alison Bamberg
  • Publication number: 20120148528
    Abstract: Embodiments herein concern compositions and methods for treating a subject having or suspected of developing a pulmonary disorder or cancer. Certain embodiments concern modulating protein tyrosine phosphatase non-receptor type 13 (PTPN13) expression and/or activity in a subject to treat uncontrolled cellular growth in the subject.
    Type: Application
    Filed: November 8, 2011
    Publication date: June 14, 2012
    Inventors: David W.H. Riches, Alison Bamberg